Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Bayer Schering Will Build $129 Million Beijing R&D Center

publication date: Feb 12, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Bayer Schering Pharma of Germany will invest $129 million to build a global R&D center located in Beijing. The investment will take place over five years. For Bayer Schering, China is the third largest market, and the company already has already located R&D centers in the US and Europe, its two markets that are larger than China. The Beijing center will be very mindful of the clinical profile and medical needs of Asian patients, though the center is not exclusively devoted to the Asian market. More details...

Stock Symbol: (Frankfurt: SCH)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners